ENTERA BIO LTD. Increase (Decrease) in Other Current Assets
ENTERA BIO LTD. (ENTX) reported Increase (Decrease) in Other Current Assets of $48.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2026-08-07
- ENTERA BIO LTD. increase (decrease) in other current assets for the quarter ending 2026-06-30 was -$46.00K.
- ENTERA BIO LTD. increase (decrease) in other current assets for the quarter ending 2026-03-31 was $94.00K, a 71.77% decline year-over-year.
- ENTERA BIO LTD. increase (decrease) in other current assets for the quarter ending 2025-12-31 was $10.00K.
- ENTERA BIO LTD. increase (decrease) in other current assets for the quarter ending 2025-09-30 was -$33.00K.
- ENTERA BIO LTD. increase (decrease) in other current assets for fiscal 2025 was $229.00K, a 1535.71% increase from fiscal 2024.
- ENTERA BIO LTD. increase (decrease) in other current assets for fiscal 2024 was $14.00K.
- ENTERA BIO LTD. increase (decrease) in other current assets for fiscal 2023 was -$56.00K, a 240.00% decline from fiscal 2022.
- ENTERA BIO LTD. increase (decrease) in other current assets for fiscal 2022 was $40.00K.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 9 month as first filed | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$46.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $48.00K 10-Q · filed 2026-08-07 | $58.00K derived: sum of 3 quarters · filed 2026-08-07 | $25.00K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2026-03-31 | $94.00K 10-Q · filed 2026-05-08 | $104.00K derived: sum of 2 quarters · filed 2026-05-08 | $71.00K derived: sum of 3 quarters · filed 2026-05-08 | -$10.00K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$23.00K derived: sum of 2 quarters · filed 2026-03-27 | -$104.00K derived: sum of 3 quarters · filed 2026-08-07 | $229.00K 10-K · filed 2026-03-27 | |
| 2025-09-30 | -$33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$114.00K derived: sum of 2 quarters · filed 2026-08-07 | $219.00K 10-Q · filed 2025-11-14 | $191.00K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-06-30 | -$81.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $252.00K 10-Q · filed 2026-08-07 | $224.00K derived: sum of 3 quarters · filed 2026-08-07 | $34.00K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-03-31 | $333.00K 10-Q · filed 2026-05-08 | $305.00K derived: sum of 2 quarters · filed 2026-05-08 | $115.00K derived: sum of 3 quarters · filed 2026-05-08 | $23.00K derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | -$28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$218.00K derived: sum of 2 quarters · filed 2026-03-27 | -$310.00K derived: sum of 3 quarters · filed 2026-03-27 | $14.00K 10-K · filed 2026-03-27 | |
| 2024-09-30 | -$190.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$282.00K derived: sum of 2 quarters · filed 2025-11-14 | $42.00K 10-Q · filed 2025-11-14 | $133.00K 10-Q · filed 2024-11-08 | -$128.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$92.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $232.00K 10-Q · filed 2025-08-08 | $62.00K derived: sum of 3 quarters · filed 2025-08-08 | -$180.00K derived: sum of 4 quarters · filed 2025-08-08 | |
| 2024-03-31 | $324.00K 10-Q · filed 2025-05-09 | $154.00K derived: sum of 2 quarters · filed 2025-05-09 | -$88.00K derived: sum of 3 quarters · filed 2025-05-09 | -$91.00K derived: sum of 4 quarters · filed 2025-05-09 | |
| 2023-12-31 | -$170.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$412.00K derived: sum of 2 quarters · filed 2025-03-28 | -$415.00K derived: sum of 3 quarters · filed 2025-03-28 | -$56.00K 10-K · filed 2025-03-28 | |
| 2023-09-30 | -$242.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$245.00K derived: sum of 2 quarters · filed 2024-11-08 | $114.00K 10-Q · filed 2024-11-08 | -$226.00K derived: sum of 4 quarters · filed 2024-11-08 | |
| 2023-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $356.00K 10-Q · filed 2024-08-09 | $16.00K derived: sum of 3 quarters · filed 2024-08-09 | -$308.00K derived: sum of 4 quarters · filed 2024-08-09 | |
| 2023-03-31 | $359.00K 10-Q · filed 2024-05-10 | $19.00K derived: sum of 2 quarters · filed 2024-05-10 | -$305.00K derived: sum of 3 quarters · filed 2024-05-10 | -$700.00K derived: sum of 4 quarters · filed 2024-05-10 | |
| 2022-12-31 | -$340.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | -$664.00K derived: sum of 2 quarters · filed 2024-03-08 | -$1.06M derived: sum of 3 quarters · filed 2024-03-08 | $40.00K 10-K · filed 2024-03-08 | |
| 2022-09-30 | -$324.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$719.00K derived: sum of 2 quarters · filed 2023-11-14 | $380.00K 10-Q · filed 2023-11-14 | $175.00K derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | -$395.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $704.00K 10-Q · filed 2023-08-11 | $499.00K derived: sum of 3 quarters · filed 2023-08-11 | $95.00K derived: sum of 4 quarters · filed 2023-08-11 | |
| 2022-03-31 | $1.10M 10-Q · filed 2023-05-05 | $894.00K derived: sum of 2 quarters · filed 2023-05-05 | $490.00K derived: sum of 3 quarters · filed 2023-05-05 | $315.00K derived: sum of 4 quarters · filed 2023-05-05 | |
| 2021-12-31 | -$205.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$609.00K derived: sum of 2 quarters · filed 2023-03-31 | -$784.00K derived: sum of 3 quarters · filed 2023-03-31 | -$7.00K 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$404.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$579.00K derived: sum of 2 quarters · filed 2022-11-10 | $198.00K 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | -$175.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $602.00K 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | $777.00K 10-Q · filed 2022-05-12 | ||||
| 2020-12-31 | $55.00K 10-K · filed 2022-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |